Earnings NewsPOINT Biopharma Global GAAP EPS of -$0.24, revenue of $4.87MAug. 14, 2023 9:44 AM ETPOINT Biopharma Global Inc. (PNT) StockBy: Urvi Shah, SA News Editor POINT Biopharma Global press release (NASDAQ:PNT): Q2 GAAP EPS of -$0.24. Revenue of $4.87M. Recommended For YouMore Trending NewsSee More »Related StocksSymbolLast Price% ChgPNT--POINT Biopharma Global Inc.Trending AnalysisTrending News